Matches in Wikidata for { <http://www.wikidata.org/entity/Q37071694> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- Q37071694 description "article científic" @default.
- Q37071694 description "article scientifique" @default.
- Q37071694 description "articolo scientifico" @default.
- Q37071694 description "artigo científico" @default.
- Q37071694 description "artículu científicu espublizáu en 1970" @default.
- Q37071694 description "bilimsel makale" @default.
- Q37071694 description "bài báo khoa học" @default.
- Q37071694 description "scientific article published on October 1970" @default.
- Q37071694 description "vedecký článok" @default.
- Q37071694 description "vetenskaplig artikel" @default.
- Q37071694 description "videnskabelig artikel" @default.
- Q37071694 description "vědecký článek" @default.
- Q37071694 description "wetenschappelijk artikel" @default.
- Q37071694 description "wissenschaftlicher Artikel" @default.
- Q37071694 description "наукова стаття, опублікована в жовтні 1970" @default.
- Q37071694 description "научни чланак" @default.
- Q37071694 description "գիտական հոդված հրատարակված 1970 թվականի հոկտեմբերին" @default.
- Q37071694 description "مقالة علمية نشرت في أكتوبر 1970" @default.
- Q37071694 name "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 name "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 name "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 type Item @default.
- Q37071694 label "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 label "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 label "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 prefLabel "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 prefLabel "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 prefLabel "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 P1433 Q37071694-B1758F28-8452-42E6-98B6-83ADE393A0B5 @default.
- Q37071694 P1476 Q37071694-0571A21F-A304-4E38-9FFF-CAC2FB217114 @default.
- Q37071694 P2093 Q37071694-3D306643-1279-4A84-96C1-DB3E50693B3A @default.
- Q37071694 P2093 Q37071694-9C789BC9-9638-40A8-8210-F922CD590D48 @default.
- Q37071694 P2093 Q37071694-B45CF81B-CE7A-497C-B4FA-55BBA1D8B105 @default.
- Q37071694 P2093 Q37071694-F078747B-4F15-49EB-AC2D-D2C1AFE0E6D8 @default.
- Q37071694 P2860 Q37071694-03F2E12F-86F7-4015-9E45-1C90D0D470CC @default.
- Q37071694 P2860 Q37071694-1903A871-A1EE-4DFC-8FA4-9C3EA7D96049 @default.
- Q37071694 P2860 Q37071694-1D54D5C2-A3C8-4E37-85FC-C31793E4D769 @default.
- Q37071694 P2860 Q37071694-1E64B950-3465-4763-B857-A53D62EECA6D @default.
- Q37071694 P2860 Q37071694-677FDA0A-7959-4C4D-B0BB-D538D0BDF27E @default.
- Q37071694 P2860 Q37071694-733E2331-A08A-4D34-8F55-65060DFC3B2C @default.
- Q37071694 P2860 Q37071694-98F65DB5-C323-498B-A2FF-1D3796B4C5F9 @default.
- Q37071694 P2860 Q37071694-B851EC9F-51CE-4254-ABC9-EE917E04DB86 @default.
- Q37071694 P2860 Q37071694-CF67F567-1EA3-4415-8235-FF1F122491A8 @default.
- Q37071694 P2860 Q37071694-D189FB95-3187-4FD0-925C-858C61863CC1 @default.
- Q37071694 P2860 Q37071694-E8592B76-2FC6-4684-A6CA-FC3749B6F033 @default.
- Q37071694 P304 Q37071694-6A68FF16-5266-4048-9F7B-28BBFBDC323E @default.
- Q37071694 P31 Q37071694-EA8FD6E8-F57E-44DD-9AA7-D7830DC13428 @default.
- Q37071694 P356 Q37071694-F02E85D9-F687-4822-903B-39D6282359EE @default.
- Q37071694 P407 Q37071694-5525EA1B-7170-4C56-80C1-9A51A61B32B5 @default.
- Q37071694 P433 Q37071694-4E5EC6AF-F45A-4471-B48F-ED295EBE9384 @default.
- Q37071694 P478 Q37071694-55AE61FA-44EB-45BC-9B15-2BC3D1F474FF @default.
- Q37071694 P577 Q37071694-450730B5-F292-46CB-AB9E-0EE1040B732F @default.
- Q37071694 P5875 Q37071694-0E97F4F7-0256-4FAB-BD3D-8D53B2680087 @default.
- Q37071694 P698 Q37071694-A3B96FF0-17C8-405A-870A-A71409862F00 @default.
- Q37071694 P8608 Q37071694-70EFBFCC-BF19-47A4-8E5C-CED86E214A72 @default.
- Q37071694 P921 Q37071694-46C95AF7-7582-4F83-A56D-1B3156DACDF2 @default.
- Q37071694 P921 Q37071694-4E20086D-4DB7-43D9-9620-475A888473F7 @default.
- Q37071694 P921 Q37071694-947F34A9-1F68-4497-8AA3-0E1AD7571851 @default.
- Q37071694 P932 Q37071694-893A939F-9A5A-48B6-A3F1-F5C71816B33C @default.
- Q37071694 P356 JNNP.33.5.663 @default.
- Q37071694 P698 4920799 @default.
- Q37071694 P1433 Q1599804 @default.
- Q37071694 P1476 "Controlled trial of hydroxocobalamin and riboflavine in Nigerian ataxic neuropathy" @default.
- Q37071694 P2093 "Aladetoyinbo A" @default.
- Q37071694 P2093 "Langman MJ" @default.
- Q37071694 P2093 "Osuntokun BO" @default.
- Q37071694 P2093 "Wilson J" @default.
- Q37071694 P2860 Q24683183 @default.
- Q37071694 P2860 Q28255397 @default.
- Q37071694 P2860 Q50728867 @default.
- Q37071694 P2860 Q50729890 @default.
- Q37071694 P2860 Q51245018 @default.
- Q37071694 P2860 Q51285842 @default.
- Q37071694 P2860 Q59060566 @default.
- Q37071694 P2860 Q72783442 @default.
- Q37071694 P2860 Q75670688 @default.
- Q37071694 P2860 Q75819313 @default.
- Q37071694 P2860 Q79019074 @default.
- Q37071694 P304 "663-666" @default.
- Q37071694 P31 Q13442814 @default.
- Q37071694 P356 "10.1136/JNNP.33.5.663" @default.
- Q37071694 P407 Q1860 @default.
- Q37071694 P433 "5" @default.
- Q37071694 P478 "33" @default.
- Q37071694 P577 "1970-10-01T00:00:00Z" @default.
- Q37071694 P5875 "18247505" @default.
- Q37071694 P698 "4920799" @default.
- Q37071694 P8608 "release_jg6cmesm7jfe3bsbjegfw2s7ym" @default.
- Q37071694 P921 Q1033 @default.
- Q37071694 P921 Q130365 @default.
- Q37071694 P921 Q73972 @default.
- Q37071694 P932 "493545" @default.